ostashkovadm.ru 23 amd me stock


23andMe Holding Co. analyst estimates, including ME earnings per share estimates and analyst recommendations Real-time last sale data for U.S. stock quotes. Based on 2 Wall Street analysts offering 12 month price targets for 23andMe Holding in the last 3 months. The average price target is $ with a high forecast. View live 23andMe Holding Co. chart to track its stock's price action. Find market predictions, ME financials and market news. Get real-time updates on 23andMe Holding Co. Class A Common Stock (ME) stock quotes, trades, and more. Make informed investments with Nasdaq. What is 23andMe Holding Co. (ME)'s stock price history? Over the last year, 23andMe Holding Co.'s stock price has decreased by %. 23andMe Holding Co. is.

NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for. Stock Quote & Chart Data Provided by Refinitiv. Minimum 15 minutes delayed. Note that past press releases may reflect versions of the product that may not. ME | Complete 23andMe Holding Co. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 23andMe Holding (ME) advanced chart and technical analysis tool allows you to add studies and indicators such as Moving Averages (SMA and EMA), MACD. Historical daily share price chart and data for 23andMe Holding since adjusted for splits and dividends. The latest closing stock price for 23andMe. Analyst Forecast. According to 2 analysts, the average rating for ME stock is "Strong Buy." The month stock price forecast is $, which is an increase of. Volume, M. Market Value, $M. Shares Outstanding, M. EPS (TTM), -$ P/E Ratio (TTM), N/A. Dividend Yield, N/A. Latest Dividend, N/A. Share Statistics. ME has million shares outstanding. · Valuation Ratios. PE Ratio · Enterprise Valuation. EV / Earnings · Financial Position. The company. 23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. Discover real-time 23andMe Holding Co. Class A Common Stock (ME) stock prices, quotes, historical data, news, and Insights for informed trading and. View the latest ME share price or buy & sell 23andMe stock on NASDAQ using Lightyear. 23andMe Holding Co. is a genetics-led consumer healthcare and thera.

ME - 23andMe Holding Co. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS). Get 23andMe Holding Co. (ME:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. On Wednesday 03/06/ the closing price of the 23andMe Holding Co Registered Shs -A- share was $ on NAS. Compared to the opening price on Wednesday 03/06/. How to buy 23andMe stock on Public · Sign up for a brokerage account on Public · Add funds to your Public account · Choose how much you'd like to invest in. 23andMe Mulls Possible Split, Shares Fall After Disappointing Results. DNA-testing company 23andMe said on Wednesday that it is considering splitting itself in. 23andMe has received a consensus rating of Buy. The company's average rating score is , and is based on 1 buy rating, no hold ratings, and no sell ratings. View the latest 23andMe Holding Co. (ME) stock price, news, historical charts, analyst ratings and financial information from WSJ. The Investor Relations website contains information about 23andMe, Inc.'s business for stockholders, potential investors, and financial analysts. View 23andMe Holding Co. Class A ME stock quote prices, financial information, real-time forecasts, and company news from CNN.

Feb PM · 23andMe Stock Slides After DNA-Testing Company's Disappointing Results. (The Wall Street Journal) % ; AM, Join thousands of. Real time 23andMe (ME) stock price quote, stock graph, news & analysis. Track 23andMe Holding Co - Ordinary Shares - Class A (ME) Stock Price, Quote, latest community messages, chart, news and other stock related information. Based on the key indicators obtained from 23Andme Holding's historical financial statements, 23Andme Holding Co is not in a good financial situation at this. 23andMe Holding Co. is a publicly trading personal genomics and biotechnology company based in South San Francisco, California.

(NASDAQ: ME) 23andme Holding Co's forecast annual revenue growth rate of % is not forecast to beat the US Diagnostics & Research industry's average.

one and one internet | spy volatility index

25 26 27

Copyright 2013-2024 Privice Policy Contacts